Crossmark

Inhibition of <scp>DDR</scp> 1‐ <scp>BCR</scp> signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer

Crossref DOI link: https://doi.org/10.15252/emmm.201707918

Published Online: 2018-02-09

Published Print: 2018-04

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Jeitany, Maya

Leroy, Cédric

Tosti, Priscillia

Lafitte, Marie

Le Guet, Jordy

Simon, Valérie

Bonenfant, Debora

Robert, Bruno

Grillet, Fanny

Mollevi, Caroline

El Messaoudi, Safia

Otandault, Amaëlle

Canterel‐Thouennon, Lucile

Busson, Muriel

Thierry, Alain R

Martineau, Pierre

Pannequin, Julie

Roche, Serge https://orcid.org/0000-0003-3413-3859
Sirvent, Audrey https://orcid.org/0000-0003-4555-6312
Funding

Funding for this research was provided by:

Fondation ARC pour la Recherche sur le Cancer

Institut National Du Cancer

Centre National de la Recherche Scientifique

Université de Montpellier

Institut National de la Santé et de la Recherche Médicale

Fondation de France

Ligue Contre le Cancer
License Information

Version of Record valid from 2018-02-09
More Information

Publication History

Received: 2017-04-19

Accepted: 2018-01-15

Published: 2018-02-09